Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including oligodendrocytes; strongest in megakaryocytes | 0.75 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 14792
Sealed predictions
- PPP1R14A in dopamine neurons, braak+0.75 (p 0.019) → -0.45 (p 0.230)receipt 14799
- PPP1R14A in oligodendrocytes, braak+0.25 (p 0.517) → -0.41 (p 0.276)receipt 14798
Swarm cases
receipt 14799: PPP1R14A in dopamine neurons, braak
- power
- full sample +0.15 (p 0.544, n 18), 95% CI -0.34 to +0.58. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.12 (p 0.627, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.23 (p 0.355, n 18). could be the mix.
- skeptic
- leave-one-out range +0.04 to +0.30, sign flips 0; without severely affected donors +0.15 (p 0.544, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PPP1R14A in dopamine neurons.
case closed: nothing better to follow up.
receipt 14798: PPP1R14A in oligodendrocytes, braak
- power
- full sample -0.07 (p 0.794, n 18), 95% CI -0.52 to +0.41. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.18 (p 0.465, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.22 (p 0.374, n 18). could be the mix.
- skeptic
- leave-one-out range -0.20 to +0.04, sign flips 4; without severely affected donors -0.07 (p 0.794, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PPP1R14A in oligodendrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts